Kit
2 drugs Oncology
2
approved indications
2
Approved Drugs
2
Companies
4
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (2 companies)
✓ All 2 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (4 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
NOVUGEN 1 drug
Novartis 1 drug
By Therapeutic Area
Oncology 1 drugs
Other 1 drugs
Drugs by Company PRO
NOVUGEN 1 drug
Novartis 1 drug
By Therapeutic Area
Oncology 1 drugs
PAZOPANIB HYDROCHLORIDE
Other 1 drugs
VOTRIENT
Indications Treated
Renal Cell CarcinomaSoft Tissue SarcomaAdvanced renal cell carcinomaAdvanced soft tissue sarcoma
All Drugs Targeting Kit
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| PAZOPANIB HYDROCHLORIDE | NOVUGEN | 2023 | 2 | Oncology |
| VOTRIENT | Novartis | 2009 | 2 |